319 related articles for article (PubMed ID: 21102997)
1. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
Krystal AD; Lankford A; Durrence HH; Ludington E; Jochelson P; Rogowski R; Roth T
Sleep; 2011 Oct; 34(10):1433-42. PubMed ID: 21966075
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia.
Lankford A; Rogowski R; Essink B; Ludington E; Heith Durrence H; Roth T
Sleep Med; 2012 Feb; 13(2):133-8. PubMed ID: 22197474
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in adults with primary insomnia.
Roth T; Rogowski R; Hull S; Schwartz H; Koshorek G; Corser B; Seiden D; Lankford A
Sleep; 2007 Nov; 30(11):1555-61. PubMed ID: 18041488
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: a randomized, double-blind, placebo-controlled crossover study.
Scharf M; Rogowski R; Hull S; Cohn M; Mayleben D; Feldman N; Ereshefsky L; Lankford A; Roth T
J Clin Psychiatry; 2008 Oct; 69(10):1557-64. PubMed ID: 19192438
[TBL] [Abstract][Full Text] [Related]
6. Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.
Hajak G; Rodenbeck A; Voderholzer U; Riemann D; Cohrs S; Hohagen F; Berger M; Rüther E
J Clin Psychiatry; 2001 Jun; 62(6):453-63. PubMed ID: 11465523
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
8. A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia.
Ancoli-Israel S; Krystal AD; McCall WV; Schaefer K; Wilson A; Claus R; Rubens R; Roth T
Sleep; 2010 Feb; 33(2):225-34. PubMed ID: 20175406
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of Dimdazenil in adults with insomnia disorder: results from a multicenter, randomized, double-blind, placebo-controlled phase III trials.
Huang Z; Zhan S; Chen C; Zhang R; Zhou Y; He J; Lin Z; Bao C; Zhu S; Zhao J; Zhang S; Jiang Y; Wang Y
Sleep; 2024 Feb; 47(2):. PubMed ID: 37875349
[TBL] [Abstract][Full Text] [Related]
10. Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P; Moline M; Mayleben D; Rosenberg R; Zammit G; Pinner K; Dhadda S; Hong Q; Giorgi L; Satlin A
J Clin Sleep Med; 2017 Nov; 13(11):1289-1299. PubMed ID: 29065953
[TBL] [Abstract][Full Text] [Related]
11. Effect of gaboxadol on sleep in adult and elderly patients with primary insomnia: results from two randomized, placebo-controlled, 30-night polysomnography studies.
Lankford DA; Corser BC; Zheng YP; Li Z; Snavely DB; Lines CR; Deacon S
Sleep; 2008 Oct; 31(10):1359-70. PubMed ID: 18853933
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
Zammit G; Erman M; Wang-Weigand S; Sainati S; Zhang J; Roth T
J Clin Sleep Med; 2007 Aug; 3(5):495-504. PubMed ID: 17803013
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.
Fietze I; Bassetti CLA; Mayleben DW; Pain S; Seboek Kinter D; McCall WV
Drugs Aging; 2022 Oct; 39(10):795-810. PubMed ID: 36098936
[TBL] [Abstract][Full Text] [Related]
14. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
Walsh JK; Thacker S; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2009 Sep; 10(8):859-64. PubMed ID: 19345644
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study.
Li Y; Zhang R; Zhou Y; Bao C; Lin Z; Chen C; He J; Jin Z; Song L; Zhang M; Guo S; Jiang Y; Zhao Z
Sleep; 2024 Feb; 47(2):. PubMed ID: 37864827
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled, multicenter, 28-day, polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance.
Furey SA; Hull SG; Leibowitz MT; Jayawardena S; Roth T
J Clin Sleep Med; 2014 Oct; 10(10):1101-9. PubMed ID: 25317091
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
Lydiard RB; Lankford DA; Seiden DJ; Landin R; Farber R; Walsh JK
J Clin Sleep Med; 2006 Jul; 2(3):309-15. PubMed ID: 17561543
[TBL] [Abstract][Full Text] [Related]
19. A polysomnography study of eszopiclone in elderly patients with insomnia.
McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
[TBL] [Abstract][Full Text] [Related]
20. Treatment of elderly primary insomnia patients with EVT 201 improves sleep initiation, sleep maintenance, and daytime sleepiness.
Walsh JK; Salkeld L; Knowles LJ; Tasker T; Hunneyball IM
Sleep Med; 2010 Jan; 11(1):23-30. PubMed ID: 19945340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
